Clinical Updates
Cymbalta® Delayed-Release Capsule Launch
Effective December 11, 2013, the generic equivalent of Cymbalta® delayed-release capsules (duloxetine HCI) was released,…
Launch of Generic Aciphex® 20mg Tablets
On Friday, November 8, Lupin Pharmaceuticals, Inc., launched the generic equivalent of Aciphex® delayed-release tablets…
FDA Approval for ZORVOLEX™
October 18, 2013 – Iroko Pharmaceuticals, LLC, announced that the FDA had approved ZORVOLEX™ (diclofenac)…
Launch of Generic Niaspan® Extended-Release Tablets
Teva Pharmaceuticals has launched generic Niaspan® Extended-Release Tablets, which received FDA Approval in April 2005…
Generic Lidoderm 5% Patch Launches
Actavis Pharma, Inc. has launched generic Lidoderm® (lidocaine patch 5%), which received FDA approval on…
Generic Trilipix Capsules Launch
On July 15, 2013, Global Pharmaceuticals received final FDA approval and commenced shipping for generic…
Generic Zomig Launches
On May 14, 2013, Global Pharmaceuticals launched the Authorized Generic (AG) for Zomig and Zomig-ZMT…
FDA Bans Generic Version of Oxycontin
On the day when the patent for the original version of OxyContin was set to…
Generic Zovirax® Launches
On Wednesday, April 3, generic Zovirax® ointment launched. Annual US brand sales of the 30gm…
Generic Luvox® CR Launches
On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of…
